Literature DB >> 2895386

Possible exacerbation of myasthenia gravis by ciprofloxacin.

B Moore, M Safani, J Keesey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895386     DOI： 10.1016/s0140-6736(88)91627-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Ciprofloxacin and myasthenia gravis.

Authors:  C J Mumford; L Ginsberg
Journal:  BMJ       Date:  1990-10-06

Review 2.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 3.  Myasthenic crisis.

Authors:  David Lacomis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Probable exacerbation of myasthenia gravis by ofloxacin.

Authors:  E Azevedo; J A Ribeiro; J Polónia; C Pontes
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

Review 5.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 6.  Clinical features and management of adverse effects of quinolone antibacterials.

Authors:  J H Paton; D S Reeves
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.